Effect of 2-y n−3 long-chain polyunsaturated fatty acid supplementation on cognitive function in older people: a randomized, double-blind, controlled trial

Personal Social Services Research Unit. Dementia UK. London, United Kingdom: Alzheimer’s Society, 2007.

Ferri, 2005, Global prevalence of dementia: a Delphi consensus study, Lancet, 366, 2112, 10.1016/S0140-6736(05)67889-0

Gillette Guyonnet, 2007, IANA task force on nutrition and cognitive decline with aging, J Nutr Health Aging, 11, 132

Luchsinger, 2004, Dietary factors and Alzheimer’s disease, Lancet Neurol, 3, 579, 10.1016/S1474-4422(04)00878-6

Futterman, 1964, The fatty acid composition of human retinal vitamin a ester and the lipids of human retinal tissue, Invest Ophthalmol, 3, 441

Svennerholm, 1968, Distribution and fatty acid composition of phosphoglycerides in normal human brain, J Lipid Res, 9, 570, 10.1016/S0022-2275(20)42702-6

Bazan, 2006, Cell survival matters: docosahexaenoic acid signaling, neuroprotection and photoreceptors, Trends Neurosci, 29, 263, 10.1016/j.tins.2006.03.005

Uauy R, Dangour AD. Nutrition in brain development and aging: role of essential fatty acids. Nutr Rev 2006; 64: S24 – 33; discussion S72–91.

Ortega, 1997, Dietary intake and cognitive function in a group of elderly people, Am J Clin Nutr, 66, 803, 10.1093/ajcn/66.4.803

Kalmijn, 2004, Dietary intake of fatty acids and fish in relation to cognitive performance at middle age, Neurology, 62, 275, 10.1212/01.WNL.0000103860.75218.A5

Feart, 2009, Adherence to a Mediterranean diet, cognitive decline, and risk of dementia, JAMA, 302, 638, 10.1001/jama.2009.1146

Barberger-Gateau, 2002, Fish, meat, and risk of dementia: cohort study, BMJ, 325, 932, 10.1136/bmj.325.7370.932

Morris, 2003, Consumption of fish and n−3 fatty acids and risk of incident Alzheimer disease, Arch Neurol, 60, 940, 10.1001/archneur.60.7.940

Morris, 2005, Fish consumption and cognitive decline with age in a large community study, Arch Neurol, 62, 1849, 10.1001/archneur.62.12.noc50161

Huang, 2005, Benefits of fatty fish on dementia risk are stronger for those without APOE epsilon4, Neurology, 65, 1409, 10.1212/01.wnl.0000183148.34197.2e

van Gelder, 2007, Fish consumption, n−3 fatty acids, and subsequent 5-y cognitive decline in elderly men: the Zutphen Elderly Study, Am J Clin Nutr, 85, 1142, 10.1093/ajcn/85.4.1142

Albanese, 2009, Dietary fish and meat intake and dementia in Latin America, China, and India: a 10/66 Dementia Research Group population-based study, Am J Clin Nutr, 90, 392, 10.3945/ajcn.2009.27580

Laurin, 2003, Omega-3 fatty acids and risk of cognitive impairment and dementia, J Alzheimers Dis, 5, 315, 10.3233/JAD-2003-5407

Engelhart, 2002, Diet and risk of dementia: does fat matter?: the Rotterdam Study, Neurology, 59, 1915, 10.1212/01.WNL.0000038345.77753.46

Devore, 2009, Dietary intake of fish and omega-3 fatty acids in relation to long-term dementia risk, Am J Clin Nutr, 90, 170, 10.3945/ajcn.2008.27037

Kroger, 2009, Omega-3 fatty acids and risk of dementia: the Canadian Study of Health and Aging, Am J Clin Nutr, 90, 184, 10.3945/ajcn.2008.26987

van de Rest, 2008, Effect of fish oil on cognitive performance in older subjects: a randomized, controlled trial, Neurology, 71, 430, 10.1212/01.wnl.0000324268.45138.86

Lim WS, Gammack JK, Van Niekerk J, Dangour AD. Omega 3 fatty acid for the prevention of dementia. Cochrane Database Syst Rev 2006; CD005379.

Dangour, 2006, Nutr J, 5, 20, 10.1186/1475-2891-5-20

Folstein, 1975, “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician, J Psychiatr Res, 12, 189, 10.1016/0022-3956(75)90026-6

Scientific Advisory Committee on Nutrition. Advice on fish consumption: benefits and risks. London, United Kingdom: The Stationary Office, 2004.

Kris-Etherton, 2002, Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease, Circulation, 106, 2747, 10.1161/01.CIR.0000038493.65177.94

Department of Education and Science. Burnham further education committee grading courses. London, United Kingdom: HMSO, 1972.

Dangour, 2009, Fish consumption and cognitive function among older people in the UK: baseline data from the OPAL study, J Nutr Health Aging, 13, 198, 10.1007/s12603-009-0057-2

Goldberg D. The detection of psychiatric illness by questionnaire. London, United Kingdom: Oxford University Press, 1972.

Vellas, 2008, Endpoints for trials in Alzheimer’s disease: a European task force consensus, Lancet Neurol, 7, 436, 10.1016/S1474-4422(08)70087-5

Delis DC, Kramer JH, Kaplan E, Ober BA. California Verbal Learning Test. New York, NY: Psychological Corporation, 1987.

Tierney, 2009, A randomized double-blind trial of the effects of hormone therapy on delayed verbal recall in older women, Psychoneuroendocrinology, 34, 1065, 10.1016/j.psyneuen.2009.02.009

Durga, 2007, Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: a randomised, double blind, controlled trial, Lancet, 369, 208, 10.1016/S0140-6736(07)60109-3

Wechsler D. Wechsler memory scale—revised manual. San Antonio, TX: Psychological Corporation, 1987.

van Niekerk, 2004, The development of new tests of source memory and a new approach to the testing of equivalence of parallel versions, Aging Neuropsychol Cogn, 11, 416, 10.1080/13825580490521377

Richards, 1999, Lifetime cognitive function and timing of the natural menopause, Neurology, 53, 308, 10.1212/WNL.53.2.308

Smith A. Symbol letter modalities test. Revised manual. Los Angeles, CA: Western Psychological Services, 1982.

Cox BD, Huppert FA, Whichelow MJ. The Health and Lifestyle Survey: seven years on. Aldershot, United Kingdom: Dartmouth Pub Co, 1993.

Wechsler D. Wechsler adult intelligence scale—revised. New York, NY: The Psychological Corporation, 1981.

Goodglass H, Kaplan E. Assessment of dysphasia and related disorders. Philadelphia, PA: Lea and Febiger, 1983.

Maylor, 1993, Aging and forgetting in prospective and retrospective memory tasks, Psychol Aging, 8, 420, 10.1037/0882-7974.8.3.420

London School of Hygiene and Tropical Medicine. The OPAL study. Homepage. Available from: http://opal-study.org.uk (cited 15 September 2009).

Connor, 2000, Cheek cell phospholipids in human infants: a marker of docosahexaenoic and arachidonic acids in the diet, plasma, and red blood cells, Am J Clin Nutr, 71, 21, 10.1093/ajcn/71.1.21

Hoffman, 1999, Fatty acid profile of buccal cheek cell phospholipids as an index for dietary intake of docosahexaenoic acid in preterm infants, Lipids, 34, 337, 10.1007/s11745-999-0371-y

Lepage, 1986, Direct transesterification of all classes of lipids in a one-step reaction, J Lipid Res, 27, 114, 10.1016/S0022-2275(20)38861-1

Samsa, 1999, Determining clinically important differences in health status measures: a general approach with illustration to the Health Utilities Index Mark II, Pharmacoeconomics, 15, 141, 10.2165/00019053-199915020-00003

Norman, 2000, Demographically corrected norms for the California Verbal Learning Test, J Clin Exp Neuropsychol, 22, 80, 10.1076/1380-3395(200002)22:1;1-8;FT080

Goldberg, 1997, The validity of two versions of the GHQ in the WHO study of mental illness in general health care, Psychol Med, 27, 191, 10.1017/S0033291796004242

McMahon, 2006, A controlled trial of homocysteine lowering and cognitive performance, N Engl J Med, 354, 2764, 10.1056/NEJMoa054025

Neuringer, 1986, Biochemical and functional effects of prenatal and postnatal omega 3 fatty acid deficiency on retina and brain in rhesus monkeys, Proc Natl Acad Sci USA, 83, 4021, 10.1073/pnas.83.11.4021

World Cancer Research Fund/American Institute for Cancer Research. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Washington, DC: American Institute for Cancer Research, 2007.

Hennekens, 2009, The need for large-scale randomized evidence without undue emphasis on small trials, meta-analyses, or subgroup analyses, JAMA, 302, 2361, 10.1001/jama.2009.1756

Freund-Levi, 2006, Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial, Arch Neurol, 63, 1402, 10.1001/archneur.63.10.1402

Gillette-Guyonnet, 2009, Commentary on “A roadmap for the prevention of dementia II. Leon Thal Symposium 2008.” The Multidomain Alzheimer Preventive Trial (MAPT): a new approach to the prevention of Alzheimer’s disease, Alzheimers Dement, 5, 114, 10.1016/j.jalz.2009.01.008